PEIRETTI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 111.022
NA - Nord America 7.961
AS - Asia 3.882
SA - Sud America 757
Continente sconosciuto - Info sul continente non disponibili 377
AF - Africa 157
OC - Oceania 45
Totale 124.201
Nazione #
IT - Italia 108.772
US - Stati Uniti d'America 7.730
SG - Singapore 1.495
CN - Cina 1.149
BR - Brasile 585
SE - Svezia 546
UA - Ucraina 350
VN - Vietnam 331
DE - Germania 301
GB - Regno Unito 267
FI - Finlandia 196
FR - Francia 177
IN - India 175
HK - Hong Kong 140
CA - Canada 126
BD - Bangladesh 114
NL - Olanda 107
KR - Corea 55
MX - Messico 55
AR - Argentina 53
ES - Italia 45
ZA - Sudafrica 44
AU - Australia 40
TR - Turchia 40
IQ - Iraq 39
PH - Filippine 39
RU - Federazione Russa 39
ID - Indonesia 35
PK - Pakistan 35
CH - Svizzera 31
PL - Polonia 30
AT - Austria 28
JP - Giappone 28
TW - Taiwan 28
CL - Cile 27
BE - Belgio 23
CO - Colombia 23
EG - Egitto 23
IR - Iran 22
SA - Arabia Saudita 22
VE - Venezuela 22
EC - Ecuador 19
MY - Malesia 18
MA - Marocco 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
UZ - Uzbekistan 14
GR - Grecia 13
IE - Irlanda 13
TN - Tunisia 13
AZ - Azerbaigian 11
JM - Giamaica 11
PY - Paraguay 11
ET - Etiopia 10
HR - Croazia 9
MU - Mauritius 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
IL - Israele 8
NO - Norvegia 8
OM - Oman 8
PE - Perù 8
CR - Costa Rica 7
HU - Ungheria 7
KZ - Kazakistan 7
LT - Lituania 7
LY - Libia 7
NG - Nigeria 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
NP - Nepal 6
RO - Romania 6
RS - Serbia 6
BO - Bolivia 5
KE - Kenya 5
AL - Albania 4
AM - Armenia 4
BN - Brunei Darussalam 4
GT - Guatemala 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PA - Panama 4
SN - Senegal 4
TH - Thailandia 4
UY - Uruguay 4
CI - Costa d'Avorio 3
HN - Honduras 3
KH - Cambogia 3
LB - Libano 3
LI - Liechtenstein 3
LK - Sri Lanka 3
TT - Trinidad e Tobago 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
GH - Ghana 2
KY - Cayman, isole 2
LU - Lussemburgo 2
Totale 123.798
Città #
Cagliari 104.310
Uta 3.869
Singapore 791
Ashburn 778
Fairfield 603
San Jose 440
Woodbridge 437
Chandler 399
Dallas 381
Nyköping 356
Houston 342
Boardman 318
Wilmington 268
Seattle 265
Ann Arbor 237
Cambridge 227
Beijing 222
Council Bluffs 213
Jacksonville 181
Los Angeles 148
New York 136
Santa Clara 136
Hong Kong 120
Dearborn 115
Helsinki 112
Lauterbourg 104
Shanghai 104
The Dalles 96
Hefei 94
Ho Chi Minh City 94
Boston 73
Hanoi 69
Milan 68
Nanjing 61
Buffalo 59
Seoul 53
São Paulo 52
Rome 48
Chicago 44
Orem 39
Columbus 37
San Diego 37
Redondo Beach 33
Munich 31
London 30
Toronto 29
Dong Ket 26
Redwood City 25
Sassari 24
Shenyang 24
Nuremberg 23
Phoenix 23
Selargius 22
Tokyo 22
Guangzhou 21
Atlanta 20
Chennai 20
Frankfurt am Main 20
Johannesburg 20
Nanchang 20
Hebei 19
Montreal 19
Warsaw 19
Amsterdam 18
Denver 18
Tianjin 18
Brooklyn 17
Haiphong 17
Cedar Knolls 16
Jiaxing 16
Miami 16
Mumbai 16
Rio de Janeiro 16
Yverdon 16
Baghdad 15
Manchester 15
Brussels 14
Changsha 14
Augusta 13
Curitiba 13
Poplar 13
Slough 13
Washington 13
Zhengzhou 13
Amman 12
Da Nang 12
Mexico City 12
Mountain View 12
Shenzhen 12
Stockholm 12
Ardabil 11
Belo Horizonte 11
Detroit 11
Moscow 11
Norwalk 11
Paris 11
Querétaro 11
San Francisco 11
San Mateo 11
Tashkent 11
Totale 117.528
Nome #
null 3.998
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.206
null 2.985
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.888
Pterygium and glucose-6-phosphate dehydrogenase deficiency 2.874
OCT angiography characteristics in patients with chronic CSCR complicated with polypoidal choroidal vasculopathy 2.145
Comparison of inverted flap and subretinal aspiration technique in full-thickness macular hole surgery: a randomized controlled study 2.009
Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics 2.007
mRNA Level Alterations Of Protein Involved In Cholesterol Ester Metabolism In Pterygium Fibroblast 1.915
Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts 1.767
Influence of macular choroidal thickness on visual function in highly myopic eyes 1.759
Use of a new intra-ocular spectral domain optical coherence tomography in vitreoretinal surgery 1.753
Novel P.Asp304gly mutation in best1 gene associated with atypical best vitelliform macular dystrophy phenotype and high intrafamilial variability 1.748
Photodynamic Therapy with Verteporfin for Corneal Neovascularization 1.720
Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: A prospective study of elective cases 1.707
Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. 1.694
Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy 1.667
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 1.617
null 1.601
Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy 1.558
Terapia Fotodinamica dello Pterigio con Verteporfina 1.548
Unilateral retinitis pigmentosa: A proposal of genetic pathogenic mechanisms 1.542
Bilateral noncalcified astrocytic hamartomas in retinitis pigmentosa: Multimodal imaging evaluation over 8 years of follow-up 1.522
Infrared imaging of choroidal involvement in Leber's idiopathic stellate neuroretinitis 1.521
Proliferative Activity and Cholesterol Ester Metabolism in Primary Culture of Human Pterygium Fibroblasts 1.508
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY SECONDARY TO CHRONIC CENTRAL SEROUS CHORIORETINOPATHY 1.508
HUMAN AMNIOTIC MEMBRANE TO CLOSE RECURRENT, HIGH MYOPIC MACULAR HOLES IN PATHOLOGIC MYOPIA WITH AXIAL LENGTH OF ≥30 mm 1.506
Strategy for the management of diabetic macular edema: the European Vitreo-Retinal Society macular edema study 1.474
Current surgical treatment of age-related macular degeneration 1.470
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 1.459
Analysis of Fundus Autofluorescence in Patients with Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 1.450
Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy 1.428
Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy 1.415
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study 1.401
Antiproliferative drugs reduce pterygium fibroblast growth rate by modulating cholesterol homeostasis 1.379
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 1.371
Correspondence 1.353
null 1.350
Efficacy and safety of combined vitrectomy with intravitreal dexamethasone implant for advanced stage epiretinal membrane 1.275
Reliable Therapeutic Modalities to Treat Age-Related Macular Degeneration 1.273
Negative correlation between retinal displacement and ganglion cell layer thickness changes in eyes with epiretinal membrane 1.234
Polypoidal choroidal vasculopathy in association with choroidal nevus 1.233
Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-loaded Erythrocyte Ghost Cells. 1.207
Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy 1.201
Primary vitreoretinal lymphoma masquerading as acute posterior multifocal placoid pigment epitheliopathy 1.200
Evaluation of the Choroid in Eyes With Retinitis Pigmentosa and Cystoid Macular Edema 1.186
Polypoidal choroidal vasculopathy associated with tilted disc syndrome 1.146
The nature and frequency of neovascular age-related macular degeneration. 1.091
Photodynamic therapy of pterygium with verteporfin: a preliminary report 1.078
null 1.035
Discrepancy in current central serous chorioretinopathy classification 1.033
Photodynamic therapy in human pterygium. A preliminar report 1.019
Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium 1.011
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 1.002
Photodynamic therapy of corneal neovascularization with verteporfin 987
Unfavorable effect of photodynamic therapy in a multiple detachment of pigment epithelium complicated by choroidal neovascularization 969
Comparison between a fundus camera and scanning laser ophthalmoscope in acquiring fluorescence emission in vitro. 960
En Face Choroidal Vascularity in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy 950
Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis 945
Pseudo-vitelliform macular detachment and cuticular drusen: Exclusion of 6 candidate genes 912
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. 900
Simultaneous presentation of idiopathic macular and posterior full-thickness retinal holes successfully treated with inverted internal limiting membrane flap technique. 884
Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. 868
null 851
Repopulation of the retinal pigment epithelium after pigment epithelial rip. 821
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review. 802
Photodynamic therapy with Verteporfin (Visudyne) for pterygium 780
Diagnosis of Age Related Macular Degeneration. 765
Erratum: Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study (BioMed Research International) 761
Acute central serous chorioretinopathy and fundus autofluorescence 751
Macular hole formation following thermal laser photocoagulation in a patient with choroidal neovascular membrane and age-related macular degeneration. 750
Optical Coherence tomography in a case of a double macular hole . 709
Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary Pterygium 695
Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide 683
Choroidal vascularity map in unilateral central serous chorioretinopathy: A comparison with fellow and healthy eyes 676
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 663
Effect of the First Year of COVID-19 Pandemic on Ophthalmological Practice: A Multi-Centre Italian Study with a Focus on Medico-Legal Aspects 662
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration 651
Ocular Surface Changes Associated with Face Masks in Healthcare Personnel during COVID-19 Pandemic 638
Late Effect of Irradiation of Choroidal Circulation. 636
null 620
Oral-ocular trans infection of Epstein Barr virus. A possible new way of transmission by wearing masks in the SARS-CoV-2 era 612
Unusual clinical manifestation of sclerochoroidal calcifications. 598
Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy 597
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 596
Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous Chorioretinopathy 555
Central serous chorioretinopathy imaging biomarkers 550
Non-neovascular age-related macular degeneration with subretinal fluid 546
Analysis of Fundus Autofluorescence in Patients With Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 533
Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study 530
Interocular asymmetry in distribution of leaks in central serous chorioretinopathy 522
Age-related macular degeneration and cognitive impairment show similarities in changes of neutral lipids in peripheral blood mononuclear cells 491
Outer retinal tubulations in central serous chorioretinopathy associated with choroidal neovascularisation 484
Two-Port “Dry Vitrectomy” as a New Surgical Technique for Rhegmatogenous Retinal Detachment: Focus on Macula-on Results 466
Quantitative and Qualitative Assessments of Retinal Structure with Variable A-Scan Rate Spectralis OCT: Insights into IPL Multilaminarity 458
Correlation of sectoral choroidal vascularity with angiographic leakage in central serous chorioretinopathy 457
Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study 437
INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE for MACULAR HOLE SURGERY WITHOUT EXTRA MANIPULATION of the FLAP 435
Relationship between nerve fiber layer hemorrhages and outcomes in central retinal vein occlusion 395
null 386
Totale 117.984
Categoria #
all - tutte 170.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.464 0 679 269 195 621 444 361 329 463 540 804 759
2022/202311.689 737 1.409 1.079 992 825 1.102 714 1.222 925 787 1.382 515
2023/202412.400 589 394 355 621 1.233 1.913 2.196 796 508 845 1.473 1.477
2024/202522.136 5.114 5.357 3.587 2.326 1.397 1.392 1.283 304 375 310 277 414
2025/20268.461 611 471 1.242 829 776 612 935 398 581 893 509 604
2026/2027595 241 354 0 0 0 0 0 0 0 0 0 0
Totale 124.201